Niagen Bioscience, Inc. - Common Stock (NAGE)

CUSIP: 171077407

Q1 2026 13F Holders as of 31 Mar 2026

Security identity
Shares outstanding
79,963,455
Holder snapshot
Share change
+4,064,290
Put/Call ratio
452%
Reported price per share
$4.41
Number of holders
141
Value change
+$13,223,567
Number of buys
72
Number of sells
93

Security key

171077407

Report period

Q1 2026

Institutions

141

Top holders

10

Ownership snapshot

Top reported holders of NAGE - Niagen Bioscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
VANGUARD GROUP INC
13D/G signal
VANGUARD GROUP INC
Evidence rows
15
Latest as of
31 Dec 2025
13D/G 13F Lead comparable stake: 4.1% 13D/G row: VANGUARD GROUP INC Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
4.1%
$20,902,127
3,286,498 shares
-$4,675,567 31 Dec 2025
BlackRock, Inc.
13F
Company
13F
5.1%
$25,921,508
4,075,709 shares
31 Dec 2025
Tieton Capital Management, LLC
13F
Company
13F
2.1%
$10,463,000
1,645,093 shares
31 Dec 2025
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
13F
2%
$10,282,543
1,616,752 shares
31 Dec 2025
UBS Group AG
13F
Company
13F
1.8%
$8,978,679
1,411,742 shares
31 Dec 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
1.6%
$8,237,043
1,294,863 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
141
Shares
36,661,656
Rows available
141
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
169
Q1 2026 holders
141
Holder diff
-28
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .